Dov Rothman
Education
Ph.D., business administration, Haas School of Business, University of California, Berkeley; M.Phil., development studies, Cambridge University; B.A., political science, University of California, Berkeley
Summary of Experience
Dr. Rothman specializes in the economic analysis of antitrust and competition issues. He is retained by private parties to present analyses to the US Department of Justice (DOJ) and the US Federal Trade Commission (FTC). He is also retained by and has testified for the FTC as an expert witness in merger litigation. In addition to his merger work, Dr. Rothman has worked on multiple joint conduct and unilateral conduct matters.
Dr. Rothman is a senior editor of the Antitrust Law Journal. He has published research in outlets including Antitrust Law Journal, The Antitrust Source, Journal of Health Economics, Journal of Competition Law & Economics, and Concurrences: Competition Law Journal. Dr. Rothman has taught a course on the economics of merger analysis in the economics department at Harvard University. Prior to joining Analysis Group, he was an assistant professor at Columbia University.
Provided Expert Testimony
Additional Cases
- Federal Trade Commission, et al. v. Penn State Hershey Medical Center, et al.
- High-Tech Employee Class Action Involving Alleged No-Poaching Agreements
- In re Countrywide Financial Corp. Mortgage Marketing and Sales Practices Litigation
- In re: TFT-LCD (Flat Panel) Antitrust Litigation
- Pat Cason-Merenda et al v Detroit Medical Center et al
- Pharmaceutical Off-Label Promotion & Kickbacks Settlements
- United States of America v. Krikor Topouzian
- US et al. v. Anthem Inc. et al.
-
Mergers and Monopsony: The Anthem-Cigna Merger
Antitrust Economics in a Time of Upheaval: Recent Competition Policy Cases on Two Continents, Ch. 7, pp. 148–172, 2023
2023 -
Up or Down? The Price Effects of Mergers of Intermediaries
Antitrust Law Journal 82 (2019) 643–677
2019 -
A Primer on Bargaining: How Mergers May Affect Negotiated Prices
The Antitrust Source, April 2018
2018 -
Comment on ‘The Flaws in Using the Hypothetical Monopolist Test from the ‘Payor Perspective’ in Health Care Merger Cases,’ by Field, Fisher, and Coglianese
The Antitrust Source, December 2017
2017 -
The Economics of Pass-Through With Production Constraints
Journal of Competition Law & Economics, 12(2), 279–285
2016 -
The Fallacy Of Inferring Collusion From Countercyclical Prices
Antitrust Section of the American Bar Association, Economic Committee Newsletter, Volume 14, Number 1
2015 -
A Note on the Economics of Pass-Through with Two-Part Tariff Pricing
Journal of Competition Law & Economics, May 2015
2015 -
Average overcharge models and determining individual harm in collective actions
Concurrences N° 2-2015, pp. 38-44
2015 -
A Modified Approach to Random Selection of Bellwether Cases
Bloomberg BNA's Product Safety & Liability Reporter, July 6, 2015
2015Holian M, Rothman D, Toniatti D
-
Applying Econometrics to Address Class Certification
Econometrics: Legal, Practical, and Technical Issues (Second Edition)
2014Cremieiux P, Decter A, Levin C, McFarland H, Nelson P, Rothman D, Smith D
-
Random Selection Is Best For MDL Bellwether Trials
Law360, October 20, 2014
2014Brown L, Holian M, Rothman D
-
Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction
Appl Health Econ Health Policy. 2009;7(1):61-70
2009White A, Birnbaum HG, Rothman D, Katz N
-
January 22, 2021
-
July 20, 2021
-
April 5, 2022
-
September 6, 2023
-
August 29, 2023
-
August 14, 2023
-
September 26, 2022
-
March 17, 2022